Follow the latest updates in business, technology, and research from Lattice Biologics Ltd. 
Your News & Updates
CEO's Message CEO
It's 2016 and the Lattice team is off and running!  We were overjoyed to announce the launch of the Lattice Biologics Ltd. RTO at the beginning of the month and we can't wait to share more information about the exciting new biologic products we are currently developing.
I wanted to start out the year by communicating with our stakeholders to provide an overview of the outlook, goals, and timelines we expect for 2016.

We are spending January traveling the globe to attend major industry conferences and trade shows to connect with investors and increase visibility for Lattice Biologics Ltd. and host investor roadshows.  We have been encouraged by the great wave of interest in regenerative medicine, medtech, and biotech  we have experienced at these meetings.  As disruption continues in resources, medtech offers a safe haven for investors. In turbulent times, the  Healthcare sector generally performs well.

Employee Growth: Adding to our high-performing team, we have made several new key hires in Quality Assurance, Quality Control, Sales, Processing Technicians, and R&D to support the growth of our business in 2016 and beyond.

Ramping-up Distribution: As we continue to build our distribution capability, we engage in the basic blocking and tackling that is needed on a daily basis.  It's been extremely rewarding seeing this team push straight through each  challenge  that pops up. The big take-away is that we are continuing to strengthen our balance sheet while simultaneously doubling our processing capability.  
I believe  the  best way to demonstrate our progress to the investment community is to communicate our progress on a quarterly basis by breaking down the numbers in 3 main areas:
  1. Hospitals currently buying Lattice products
  2. Distributors currently carrying our product line
  3. Exclusive sales representatives 
We have set targets for each of these areas and plan to communicate detailed progress on the figures--and, specifically, the quarter over quarter changes--each quarter at our shareholder conference calls.
Revenue: In expectation of meeting our 2017 revenue goals, we are planning to recruit 25-50 new surgeons throughout 2016.  We will execute on this goal by meeting with key surgeons individually and at targeted trade shows and relevant seminars and by hiring dedicated sales representatives with industry experience to identify and secure valuable surgeon relationships.

Research and Development: As a major part of our R&D efforts, we are planning to initiate a Phase I Safety Trial for burn patients in Q2 2016.  

Additionally, our Project Manager / Product Development Director,  Dr. Christopher Bradley, PhD, and our Sr. Research Scientist, Dr. Milla Zakharova,  PhD, are currently conducting a series of   studies designed elucidate the various components of the Extracellular Matrix (ECM) technology we are developing to further strengthen our patent position in this speciality. We expect to share the results of these efforts in Q3 2016.
If you enjoy these newsletters, please share them with your friends and colleagues.   As always, we appreciate your support on this journey!  

Guy Cook,  CEO
Lattice Biologics Ltd.
Lattice in the News  News
"Scottsdale biotech debuts on Toronto stock exchange"
Jan 4, 2016 

Healthcare Inc. | Angela Gonzales reports:
Lattice Biologics Ltd. (TSX Venture: LBL) made its debut on the Toronto Stock Exchange today, with an opening price of 35 cents a share.

"This new access to capital will give the Scottsdale-based stem cell company a chance to launch clinical trials and acquire other companies," said  Guy Cook, CEO of Lattice Biologics. "We hope to announce a couple of acquisitions in the first quarter of 2016.  They would be complementary to our stem cell technology."  

The company's stem cell technology is used to help burn victims heal more quickly.   Plans call for launching a clinical trial in Canada this year, followed by other trials in the U.S.   Cook said he is interested in reaching out to Maricopa Medical Center's world renowned burn unit for possible clinical trials.

With 25 employees, Lattice Biologics is expected to hire another five to 15 people in 2016, Cook said. He said he'll need technicians, scientists, quality control and quality assurance positions - jobs that either require a bachelor's or PhD.

Upcoming Events  Upcoming
Seattle, Vancouver, Calgary
[ January 25 - 27 ] 

Want to know more about our offering?  Contact us if you are interested in attending any of these meetings to learn more about our company, technology, and stock.


Monday, January 25: 

Seattle, WA United States 


Tuesday, January 26: 

Vancouver, British Columbia Canada 


Wednesday, January 27: 

Calgary, Alberta Canada

Recent Industry Events  Recent
J.P. Morgan 34th Annual Healthcare Conference
San Francisco, CA
[ January 11 - 14 ] 

Lattice Biologics Ltd. was honored to participate in J.P. Morgan's exclusive invitation-only Healthcare Conference in San Francisco. This is the largest and most informative healthcare investment symposium in the industry which brings together global industry leaders, emerging fast-growth companies, innovative technology creators, globally minded service providers, and members of the investment community. The event included  corporate leaders, financial sponsors, and institutional investors to explore market and sector trends.

Follow the discussion and catch all the insights from this year on Twitter  #JPM16
3rd Annual AlphaNorth Capital Conference
Atlantis Resort, Paradise Island, the Bahamas
[ January 15 - 17 ] 

The 3rd annual conference featured some of the best small cap innovators in the technology, biotech and healthcare spaces and connects them with the top institutional and specialist brokers in North America through a full day series of one-on-one meetings. 

This conference is a one-stop-shop opportunity for fund managers, investment advisors and wealth management professionals looking for insight and possible new investment ideas through valuable one-on-one sessions with small-cap companies. Last year there were 39 small-cap companies representing technology, healthcare, financial, consumer products and special situation sectors who were eager to outline the investment opportunity of their companies to the over 50 investment professionals in attendance. The conference also included social events that offered the opportunity to learn more about the companies from a different perspective.

Follow the discussion on Twitter  #AlphaNorth
Stay Up on Stock  Stock
Get the latest info on our newly trading TSX-V:LBL stock.
For more information or assistance with how to buy, contact us.
Join Lattice at The Open!  Open

Email us to request availability for exclusive Skybox access with our executives on the 16th Hole at the  Waste Management Phoenix Open 2016. 

[ Wednesday, February 3 - Saturday, February 6, 2016 ]

Lattice will be hosting private facility tours at our Scottsdale Headquarters, one-on-one meetings with our top executives, and exclusive Appreciation Days at our Skybox on the 16th hole during the Open.  Do not miss the chance to sign-up for these limited spots.  We hope you can join us! 

Come for valuable business insights in the morning and then a day of fun at our Skybox suite on the legendary 16th hole.

Lattice Biologics Ltd. | 480-563-0800 | Email | Website